07.03.2023

VERY STRONG REVENUES AND EARNINGS INCREASE IN 2022

Donaueschingen, 07/03/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its revenues by 11.1% and EBIT by 15.2% in the fiscal year 2022. As a result, the continually positive development of revenues and earnings of the last two decades could be continued.

In 2022, revenues improved from KEUR 188,178 to KEUR 209,128 (+11.1%). The “NEXUS / DE” segment increased the unconsolidated revenues from KEUR 64,616 to KEUR 69,915 (+8.2%), “NEXUS / DIS” increased from KEUR 44,292 to KEUR 51,166 (+15.5%) and “NEXUS / ROE” increased to KEUR 97,590 (previous year: KEUR 86,529) (+12.8%). The international share of total business volume was 46.4% (2021: 45.2%) and amounted to KEUR 96,978 compared to KEUR 85,134 (2021).

The consolidated earnings before interest and taxes (EBIT) rose very sharply by 15.2% to KEUR 27,788 (2021: KEUR 24,114), and EBITA rose by 12.8% from KEUR 28,872 (2021) to KEUR 32,557. EBITDA increased by 8.6% to KEUR 44,292 (2021: KEUR 40,770), and consolidated surplus increased by 13.2% to KEUR 19,769 (2021: KEUR 17,459). Earnings per share (diluted/undiluted) increased from EUR 1.09 (2021) to EUR 1.21 and thus by 11% in line with revenues.

Operating cash flow increased by 7.9% to KEUR 33,875 (2021: KEUR 31,386) and remains at a very high level. At the end of 2022, the company had cash resources at its disposal in the amount of KEUR 110,019 (31/12/2021: KEUR 26,172). In addition to the operating effects, the significant increase resulted from the proceeds from capital increases amounting to KEUR 73,124. Nexus AG had equity capital amounting to KEUR 238,946 as of 31/12/2022 (31/12/2021: KEUR 142,403). Consequently, the equity capital rate is 69.4% (31/12/2021: 57.6%). This demonstrates that Nexus AG has a sustainable and healthy balance sheet as well as sufficient capital for further financing of its European growth strategy.

At the annual general meeting on 16/05/2023, the Supervisory Board and the Executive Board will propose to pay a dividend of EUR 0.21 per share.

Downloads

You might also be interested in

- NEXUS-Gruppe
Strong sales and earnings increase in the first half-year 2023

Donaueschingen, 15 August 2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by approx. 12% and EBT by 23% in the first six months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.
- NEXUS-Gruppe
VERY STRONG SALES AND EARNINGS INCREASE IN THE FIRST QUARTER 2023

Donaueschingen, 16/05/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 11% and EBIT by approx. 28% in the first three months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.
- NEXUS-Gruppe
Very strong sales and earnings increase in the third quarter 2023

Donaueschingen, 07/11/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 14% and EBT by approx. 33% in the first nine months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.
- NEXUS-Gruppe
VERY STRONG REVENUES AND EARNINGS INCREASE IN 2023

Donaueschingen, 05/03/2024: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its revenues by 15.5% and EBT by 21% in the fiscal year 2023. As a result, the continually positive development of revenues and earnings of the last two decades could be continued.
- NEXUS-Gruppe
VERY STRONG SALES AND EARNINGS INCREASE IN THE FIRST QUARTER 2024

Donaueschingen, 14/05/2024: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 15% and EBITDA by approx. 12% in the first three months of 2024. As a result, the continually positive development of sales and earnings of the last years could be continued.